Bedaquiline is a diarylquinoline drug that demonstrates potent and selective inhibition of mycobacterial ATP synthase, and is clinically administered for the treatment of multi-drug resistant tuberculosis. Due to its excellent activity and novel mechanism of action, bedaquiline has been the focus of a number of synthetic studies. This review will discuss these synthetic approaches, as well as the synthesis and bioactivity of the numerous derivatives and molecular probes inspired by bedaquiline.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2020.127172 | DOI Listing |
Publication Analysis
Top Keywords
synthetic approaches
8
bedaquiline
4
approaches bedaquiline
4
bedaquiline derivatives
4
derivatives bedaquiline
4
bedaquiline diarylquinoline
4
diarylquinoline drug
4
drug demonstrates
4
demonstrates potent
4
potent selective
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!